Client Alert: DOJ Reclassifies Medical Marijuana from Schedule I to Schedule III Under the Controlled Substances Act, Raising New Considerations for Florida Employers
On April 23, 2026, the U.S. Department of Justice (“DOJ”) announced a significant change in the treatment of medical marijuana under the Controlled Substances Act (“CSA”), moving certain [...]

